Health
Hematopoietic stem cell transplants may provide long-term benefit for people with MS – EurekAlert
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS)…
MINNEAPOLIS – A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. The research is published in the January 20, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after…
-
Noosa News18 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General18 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
General16 hours agoRussian barrage kills 25 in Ukraine city as Zelenskyy holds talks with Turkish leader
-
General20 hours agoPerth man charged after investigation into organised crime and tobacco store attacks